Background: Rapid diagnostic tests (RDTs) that detect the malaria antigen histidine-rich protein 17 2 (HRP2) are widely used in endemic areas globally to confirm Plasmodium falciparum infection 18 in febrile patients. The emergence of parasites lacking the gene encoding HRP2 and escaping 19
continues to be the predominant species with an estimated global incidence of more than 2228 48 million cases and about 405,000 deaths reported in 2018 (1). Immunochromatographic rapid 49 diagnostic tests (RDTs), which use membrane-bound antibodies to detect parasite proteins in 50 finger-prick blood samples, play a crucial role in malaria control successes in disease endemic 51 countries. Early diagnosis is critical to malaria elimination and eradication programs and RDT 52 deployment is an important component of the strategy. As a result, the global availability and 53 scale of use of RDTs has increased dramatically over the last 10 years (2). Most RDTs used 54 worldwide detect P. falciparum histidine-rich protein 2 (pfHRP2) and/or Plasmodium lactate 55 dehydrogenase (pLDH) antigens. Some studies have shown that at least some pfHRP2-based 56
RDTs also detect P. falciparum histidine-rich protein 3 (pfHRP3) due to a shared antigenic 57 epitope (2-5). In sub-Saharan Africa, which bears 90% of the global malaria burden, RDTs 58 accounted for 74% of diagnostic testing among suspected malaria cases in 2015, and pfHRP2-59 based tests were the most widely used (2). 60
Parasites with pfhrp2 and/or pfhrp3 genes (pfhrp2/3) deletions were first observed in South 61
America and increasing reports of false-negative RDT results due to these parasites have now 62 emerged from selected region of Africa and Asia (6) (7) (8) . In some countries, a high proportion of diagnostic guidelines (9, 10). However, before undertaking any drastic changes in diagnostic 65 testing policies or deploying less sensitive, less heat stable RDTs that detect alternative antigens, 66 malaria programs need, robust epidemiological data about local pfhrp2/3 deletion prevalence. 67
The World Health Organization has prioritized studies of these parasites and developed a 68 protocol for pfhrp2/3 deletion surveillance (11). However, confirmation of pfhrp2/3 deletions using 69 current techniques is challenging and time consuming. Most studies of pfhrp2 and pfhrp3 70 deletions deploy conventional nested PCR (nPCR) amplification of several genes followed by 71 gel-electrophoresis (12) . In this genotyping approach, at least three independent genes are used 72
to ascertain the quality of DNA and the presence of P. falciparum parasites to avoid unintentional 73 misclassification of pfhrp2/3 deletions in samples with low-concentration or degraded DNA (13, 74 14) . The nPCR approach requires several rounds of PCR for each gene and running the gel-75 electrophoresis for each PCR product. The nested-PCR genotyping approach is labour-intensive, 76 time consuming and is prone to contamination, particularly when deployed in large-scale 77 surveillance studies. The various nPCR methods used differ in limit of detection, and this can 78 cause type I and type II errors. Further, performance of reported the pfhrp2 and pfhrp3 PCR is 79 variable, with wide ranging limits of detection and the risk cross-reactivity in some assays. In 80 addition, gel-electrophoresis approaches do not detect deletions masked in polyclonal infections 81 (6). 82
In this study, we report the development of a multiplex qPCR assay which simultaneously detects 83 DNA from the human host, a single-copy parasite house-keeping gene, and the pfhrp2 and 84 pfhrp3 genes, including in polyclonal P. falciparum infections, in a single reaction. We report the 85 validation and application of this novel method using DNA samples derived from DBS and whole 86 blood of field isolates and clinical samples. We also deploy the assay to estimate P. falciparum 87 parasite density to rule out low parasite density as a factor for false RDT negative results (5, 13) 88 when microscopic data is unavailable or if it is not reliable. 89 90 91
Plasmodium falciparum laboratory strains 94
Initial validation of the qPCR assay was performed using culture-adapted laboratory isolates with 95 different pfhrp2 and pfhrp3 status, 3D7 (wildtype, West Africa origin), Dd2 (pfhrp2 deletion, 96
Indochina origin), HB3 (pfhrp3 deletion, Honduras origin) were obtained from the Malaria 97
Research Reference Reagent Repository (http://MR4.org). A culture-adapted isolate lacking both 98 genes (3BD5, double deletion) was also obtained from Thomas Wellems (NIAID, US) . Parasite 99 cultures of 3D7, Dd2, HB3 and 3BD5 were tightly synchronized as ring stage trophozoites in vivo 100 to simulate infected peripheral blood similar to previously used methods (15, 16) . The WHO P. 101 falciparum International standard (Pf INT), a reagent comprising lyophilised whole blood from a 102 single hyperparasitaemic individual was obtained from NIBSC UK. Undiluted, this reagent 103 represents a parasitaemia of 9.8% which is equivalent to 4.9 x 10 5 parasites per µl (15, 17) . 104
Clinical and field DNA samples 105
Clinical validation and application of the qPCR assay was performed using a convenience of 462 Tanzania have aliquots of cryopreserved blood samples and were selected for pfhrp2/3 deletion 117 study to identify pfhrp2/3-deleted parasites for culture-adaptation. 118
DNA Extraction 119
DNA was extracted from DBS from Eritrea and from whole blood from the MRL and from cultured 120 laboratory isolates using a robotic DNA extraction system (Qiasymphony, QIAGEN, Germany), whole-blood was extracted using the QIAamp Blood Mini Kit (Qiagen) into 200µl of Buffer EB as 123 per the manufacturer's instructions. 124
Multiplex qPCR development 125
Gene target selection and primer design 126
To design highly specific amplification primers that are conserved across global P. falciparum 127 isolates we carried out multiple alignment of pfhrp2 gene sequences from 1581 published P. 128 falciparum genomes (MalariaGEN) from Africa, SE Asia and South America, and a similar 129 alignment was also carried out for pfhrp3 ( Figure S1 ). The DNA sequence of the genes were 130 obtained from publicly available genomic data and the processing of the data has been described 131 in our previous report (6). We have also aligned the 3D7 DNA sequence of pfhrp2 132 (PF3D7_0831800) and pfhrp3 (PF3D7_1372200) to ensure that the conserved primers of the two 133 genes do not cross-bind and are specific to pfhrp2 and pfhrp3 respectively ( Figure S2 ). The DNA 134 sequences of pfhrp2 and pfhrp3 were aligned using Geneious v. 10 (Biomatters, USA) 135
We used Plasmodium falciparum lactate dehydrogenase (pfldh, PF3D7_1324900), coded by a 136 single-copy gene on chromosome 13, as a confirmatory gene for the presence and quality of 137 parasite DNA as well as a target for measuring parasite density. We used previously published 138 qPCR methods, with some modification of reaction conditions to amplify pfldh (13) and the 139 human beta tubulin gene (HumTuBB) (Table S1)(18). The latter was used both as an internal 140 control and as a normalizer for measurement of parasite density and for detection of pfhrp2/3 141 deletion in polyclonal infections. All primers and probes were ordered from Eurofins Scientific 142 (Germany). 143
Modification of pfhrp2 primer at the 3' end 144
Due to limited availability of suitable conserved target sequences region in pfhrp2 and pfhrp3 that 145 are dissimilar between the isoform genes and to prevent non-specific cross-binding of the pfhrp2 146 primers to pfhrp3, we used a strategy altering nucleotides located at the 3' end region (within the 147 last 5 nucleotides) of both pfhrp2 primers (Table S1 ). In total, we designed six primers with 148 different modification at the 3' end of the forward and reverse pfhrp2 primers, which were then 149 tested empirically to identify primer pairs that delivered the best specificity while maintaining 150 product yield (sensitivity). 151
Assay optimization 152
The multiplex qPCR assay designed in this study was optimized for primer and probe 153 hybridization temperature; different primer and probe concentrations and different MgCl2 154 concentrations. All the optimization analyses were performed in triplicates in a RGQ rotor-gene 155 (Qiagen, Germany). 156
The optimized final reaction conditions were performed in a final volume of 25 µl containing 1.6X 157 NH4 buffer (Bioline); 4 mM MgCl2 (Bioline); 800nM dNTPs (Bioline), 200nM of pfhrp2 primers, 158
200nM pfhrp3 primers, 120 nM of pfldh, 120 nM HumTuBB primers, 120 nM of pfhrp2 probe, 120 159 nM pfhrp3 probe, 80 nM of pfldh probe and 80 nM HumTuBB probe; 2 units of biotaq polymerase 160 and 5 µl of extracted DNA. The optimal thermocycling conditions selected were 3 mins at 95 0 C, 161 followed by 45 cycles of 15 sec at 95 0 C; 30 sec at 54 0 C and 30 sec at 72 0 C. 162
PCR efficiency, linear dynamic range and limit of detection 163
We conducted assay performance analysis based on the MIQE guidelines(19). The efficiency of 164 primer and probe combinations for each gene and linear dynamics of the qPCR assays were 165 evaluated using seven 4-fold dilutions of Pf INT (from 12500 to 3 parasites per µl). The last 166 dilution series (3 parasites per µl) was then further diluted 2-fold (from 3 to 0.38 parasites per µl) 167 to determine the measured limit of detection (LOD). The three laboratory strains (Dd2, HB3 and 168 3BD5) with known pfhrp2/3 status were included in the evaluation linear dynamic of the linear 169 range to examine the effect of DNA concentration on the cross reactivity of the primers. 170
Assay precision, analytical sensitivity and specificity 171
Performance of the multiplex qPCR pfhrp2/3 assay was evaluated by measuring coefficient of 172 i.e. 1:1, 5:1, 10:1, 100:1, 1000:1, 10,000:1, 1:100,000, 1:10,000, 1:1000, 1:100, 1:10, 1:5, 1:1. 181
We estimated the abundance of pfhrp2/3 deletion genotypes in the mix relative to the whole 182 parasite biomass as measured by relative quantification normalized to pfldh (measures the DNA 183 of all strains) and humTuBB genes. The qPCR assay was also used to detect pfhrp2/3 deletions 184 in patient samples with known polyclonal infection in patient samples, as determined by a 185 peviously published high resolution melting qPCR assay (20) . 186
Relative quantification using the pfldh gene 187
We used pfldh as a parasite target and HumTuBB as a normalizer to estimate relative parasite 188 density of each sample. The lowest parasite density (parasite per µl) with a coefficient of 189 variation of less than 35% was considered limit of quantification for the assay(21). We 190 determined the performance of the pfldh qPCR in the multiplex assay by comparing parasite 191 densities determined by a published pgmet duplex qPCR assay using samples from Eritrea (18). 192
Application to DNA from diverse field samples 193
The validated qPCR assay was then applied to DNA extracted from diverse field samples. 
Data Analysis 201
For all amplification curve analyses, the quantification cycle (Cq) threshold was placed above the 202 amplification curve of No Template Control (NTC) and any crossing point between the Cq 203 threshold and the amplification curve was considered positive (Cq value) for the specific sample. 204
To evaluate assay precision, we calculated the coefficient of variation (CV) of parasite density 205 detection (LOD), we calculated the percentage of positive samples and the lowest sample with 207 more than 3 parasites per PCR and with ≥ 95% of replicate samples detected was considered 208 LOD (19) . Similarly, to determine the lower limit of quantification (LOQ), we calculated the 209 parasite density using delta delta method and the sample with lowest parasite density (parasite 210 per µl) with a CV ≤35% was considered LOQ for the assay (21). Throughout the manuscript CV 211 refers to variation in parasite density (parasite per µl). 212
For estimation of relative abundance of pfhrp2/3 deletion in a mixed-strain infection we used 213 delta delta relative quantification method (18) For comparison of parasite density estimated by two different qPCR assays, we used STATA 225
(v 15, USA) software to perform linear regression. 226
Ethics approval and consent to participate 227
Ethical approval for collection of samples was obtained from each local ethical committee in 228 Primer and probe selection, and in silico analysis. 237
Initial assessment of pfhrp3 primers across exons 1 and 2 showed cross reactivity with 238 pfhrp2 target ( Figure S3 ) and a new set of primers within a specific conserved region of 239 exon2 of pfhrp3 was designed. After initial assessment pfhrp2 and pfhrp3 primers for 240 specificity and length of the probe, two sets of pfhrp3 primers and three sets of pfhrp2 241 primers, including primers with modifications at the 3' end, were selected for testing ( Table  242 S1). For pfhrp2 primers, of the nine combinations used, the lowest Cq value was obtained 243 when pfhrp2_F1 and pfhrp2_R2 (modification at 3' end) were combined and were selected 244 for further optimization (Table S2 ). Since one single mutation in pfhrp2 forward primer was 245 found in one sample in The Gambia and three samples in Ghana we have nucleotide 246 redundancy in the synthesis of pfhrp2_F1 primer to reflect these mutations (Table S2 ). The 247 other pfhrp2 primer combinations either produced fluorescence signal in Dd2 (pfhrp2-deleted 248 laboratory strain) due to cross binding to pfhrp3 or generated relatively higher (more 249 unfavourable) Cq values in pfhrp2-positive lab strains (HB3 and Pf INT) compared to the 250 selected primer combinations ( Figure S4 ). Interestingly, a single nucleotide change (T to G) 251 decreased the Cq value by 7 (30 to 23) while two nucleotide changes (T to G and T to G) 252 decreased the Cq value by 2 (30 to 28) (Table S2) . 253
Detection of pfhrp2 and pfhrp3 in laboratory strains 254
We followed the MIQE guidelines for optimization of the qPCR assay; for analysis and 255 The pfhrp2, pfhrp3 and pfldh qPCR assays allowed detection of three parasites per µl with a 274
Cq standard deviation (SD) of 0.58, 0.47, 0.41 respectively (Table 1A) , which corresponds to 275 parasite density CVs of 9.4%, 9.3% and 8.9% of respectively (Table 1B) . The sample with 276 dilution of the 1.5 parasite per µl showed a Cq SD of 0.80, 0.71 and 0.74, which corresponds 277 to parasite density CVs of 32.6%, 26.1% and 28.1% respectively (Table S4 ). Though the 278 assay also detected as low as 0.76 parasites per µl the SD value was very high (1.49, 1.37 279 and 1.48 respectively), and this corresponds to parasite density of CVs of 109%, 99% and 280 108% (Table S4) . Therefore, the lowest parasite density that can be quantified with CV of 281 35% lies between 1.5 and 0.76 parasites per µl. 282 
PCR efficiency and dynamic range 291
In order to measure abundance of pfhrp2 and pfhrp3 clones relative to pfldh and estimate We assessed the precision of the assay by testing seven 4-fold dilution series of the Pf INT 308 (starting concentration, 12500 parasites per µl) in triplicate on three separate occasions. The 309 mean SD for cycle quantification across the seven samples was 0.15, 0.18 and 0.17 for 310 pfhrp2, pfhrp3 and pfldh target genes respectively (Table 1A) , which corresponds to a 311 calculated parasite density of CVs of 7.4%, 7.5% and 7.8% respectively (Table 1B) . The 312 sensitivity and specificity as well as the robustness of the assay was assessed using P. (Table S4) . 317
Detecting parasites with pfhrp2/3 deletions hidden in polyclonal infections 318
The ability of the qPCR assay to detect minor or major laboratory clones with pfhrp2/3 319 deletion was assessed using artificially mixed laboratory strains Dd2, HB3, 3BD5 and Pf INT. 320
Both pfhrp2 and pfhrp3 qPCR assays showed good performance in detecting minor (as low 321 as 20%; CI, 7.94-27.05) and major (as high as 99.99%; CI, 99.99-100) pfhrp2/3-deleted 322 clones in the artificially mixed laboratory clones (Table S4 ). The pfhrp2/3 assays can also 323 detect as low as 10% pfhrp2/3 deleted clones but the value lies within the confidence interval 324 of replicate experiment of a single clone sample and therefore lacks confidence. 325
Workflow and throughput time 326
Performing the multiplex qPCR requires three steps: approximately 20 minutes for reaction 327 setup takes ~ 20 minutes, two hours for runtime 30 minutes for analysis. Over all the 328 estimated time was three hours for 72 reactions on the Rotorgene Q platform. In 329 comparison, the estimated time for the conventional method, deploying several nested PCR 330 assays in a 96-well plate format followed by electrophoresis is approximately 30 hours. Time 331 for DNA extraction is the same for both. 332 333
Validation and application of the qPCR assay on field samples 334
To determine the diagnostic sensitivity and specificity of the qPCR assay for detecting 335 pfhrp2/3 deletions in field samples and to provide population estimates of deletion 336 prevalence, we first investigated 50 DNA samples obtained from confirmed P. falciparum 337 patients from Eritrea whose pfhrp2/3 deletions were previously determined using the 338 conventional nPCR method (10). Results obtained from the qPCR assay were fully 339 concordant with previously reported results from the same samples using the conventional 340 nPCR method (10). The qPCR assay correctly detected all the pfhrp2/3 positives (100% 341 sensitivity for pfhrp2, n=19, 95% CI = (82.4%, 100%); 100% sensitivity for pfhrp3, 95% CI= 342 (66.4%; 100%), n=9) and accurately determined the absence of pfhrp2/3 in the remaining 343 samples (100% specificity for pfhrp2, n=31, 95% CI=(88.8%,100%); 100% specificity for 344 pfhrp3, n=41, 95% CI=(91.4%,100%)) ( Table 2) . We then assessed samples obtained from 345 clinical malaria patients from the MRL (n=113), Kenya (n=150) and Tanzania (n=149). For 346 the MRL samples, we selected 113 samples from countries with reported pfhrp2/3 deletion 347 or high risk of emergence of pfhrp2/3 deletion (22). The countries include Eritrea (n=1), 348
Ethiopia (n=2), Kenya (n=20), Tanzania (n=16), Uganda (n=27), Sudan (n=29), South Sudan 349 (n=10), Djibouti (n=1), Somalia (3) and east Africa (unknown country, n=2). Analysis of the 350 pfhrp2/3 status of the MRL samples by qPCR showed 1.8%, 1.8% and 6.3% pfhrp2-/3+, 351 pfhrp2+/3-and pfhrp2-/3-deletions respectively. One pfhrp2 deletion occurred in a UK 352 traveller from Sudan and five pfhrp3 deletions occurred in UK travellers from Ethiopia (1), 353
Sudan (1), South Sudan (2) and Uganda (1). There was evidence of pfhrp2/3 deletions in 354 polyclonal infections in 3.5% of MRL samples in total (Table 4) Details of the deletions in each country are shown in Table 2 . 360 As well as a positive control for parasite DNA quality, the pfldh gene was simultaneously 365 used as a parasite target for estimation of parasite density using relative quantification. After 366 assessing its sensitivity, specificity and amplification efficiency the usefulness of the qPCR 367 as an estimator of parasite density was evaluated by comparison to the previously published 368 duplex pgmet qPCR assay (18). We performed this comparison using 50 DNA samples from 369
Eritrea and the pfldh qPCR showed high degree of correlation (R 2 =0.95) with the duplex 370 pgmet qPCR (Figure 3) . The pgmet qPCR generated relatively higher parasite density 371 compared to the pfldh qPCR and this is expected as the former targets multi-copy genes in 372 the apicoplast genome, whereas the latter targets is a single-copy gene. In this study, we describe the development, validation and application of a high-throughput 383 multiplex qPCR assay for simultaneous determination of P. falciparum with pfhrp2 and 384 pfhrp3 deletion genotypes in mono-and polyclonal infections and estimation of parasite 385 density. This highly sensitive and specific method enables accurate and robust assessment 386 of parasite density between 1.5 and 0.76 parasites per µl with a CV of 35% (21). The qPCR 387 detection of each of the targets described here was achieved with high efficiency, R 2 values 388 greater than 0.96 and very low standard deviation among replicates of each dilution. An 389 additional strength of the assay is the detection of pfhrp2/3 deletions at relative abundance 390 as low as 20% and as high as 99% in mixed infections, simulated by mixture of cultured 391 parasites. This is particularly relevant in moderate to high transmission settings, where such Comparison of parasite density estimation between two qPCR methods warning signs of emergence of P. falciparum with pfhrp2/3 deletions. This would allow 395 appropriate measures to be taken to identify, respond and contain the spread of such 396 parasites before they become sufficiently abundant to impact on case management and 397 malaria control programs as has already occurred independently in South America and 398
Eritrea (12, 23) . 399
The design of the multiplex qPCR assay provides several advantages over existing detection 400 methods (5, 14, 24) . Firstly, the qPCR assay uses only one parasite target to confirm the 401 presence of DNA and to assess its quality while the gel-electrophoresis based nested PCR 402 (nPCR) methods use three target genes (5, 25, 26) . This reduces the cost and throughput 403 time and simplifies the algorithm for interpreting results. Secondly, the parasite target gene 404 (pfldh) used for DNA confirmation in the qPCR assay has a single copy, generating 405 equivalent sensitivity to the pfhrp2/3 targets. When multi-copy genes (e.g., 18SrDNA and 406 cytb) are used in the nPCR and other qPCR assays there is increased risk of false-pfhrp2/3 407 deletion calls due to sensitivity differences with the single copy pfhrp2/3 genes (14, 27) . It is 408 difficult to evaluate the accuracy of pfhrp2/3 deletion calls in the literature, as most 409 laboratories do not report the limit of detection of the nPCR methods used. Thirdly, the 410 qPCR assay uses a human house-keeping gene as internal control. Variability in DNA yield, 411 or loss, introduced during sample collection or parasite DNA extraction or qPCR 412 amplification can thus be corrected for, reducing the risk of false-pfhrp2/3 deletion calls. 413
Using conventional methods, those samples negative by 18SrDNA may be excluded from 414 further pfhrp2/3 deletion analysis as they are presumed parasite negatives, potentially 415 underestimating the prevalence of pfhrp2/3 deletions by missing those samples where 416 technical failure has caused this outcome. Fourthly, the multiplex qPCR assay accurately 417 detects laboratory P. falciparum strains and clinical samples with pfhrp2/3 deletions when 418 mixed as minor or major clones. The ability of the multiplex qPCR assay to detect pfhrp2/3 419 deletions in samples with low parasitaemia and in polyclonal infections is made possible due 420 to three unique features: the choice of a single copy parasite gene (pfldh) for DNA quality 421 confirmation; the inclusion of a human gene for normalisation and the modification of the primers. Finally, the qPCR assay can also estimate relative parasite density using the 423 human gene as a normalizer and Pf INT as a calibrator. This characteristic of the assay is 424 useful because one of the criteria for confirming deletion of pfhrp2/3 is estimation of parasite 425 density using microscopy to rule out low parasite density as a factor for lack of parasite 426 target amplification (14). However, microscopy is not always performed during community 427 surveys, and quantification of parasite density using qPCR is required (5, 13) . The qPCR 428 assay not only detects P. falciparum parasites with pfhrp2/3 deletions but also 429 simultaneously estimates parasite density in the same experiments, hence reducing time 430
and cost. 431
Our study shows the presence of pfhrp2/3 deletions in infected UK travellers for the first 432 time. While pfhrp2/3 deletions were previously reported in Eritrea (10), Ethiopia (28) and 433 Uganda (29) representative sample is higher than 5%, HRP2-based RDTs should be replaced with 441 alternative P. falciparum diagnostic tool that is not exclusively reliant on detection of HRP2 442
(11). If the prevalence is below 5% a repeat of the survey is recommended in 1-2 years and 443 the detection of pfhrp2/3 deletions in polyclonal infections by the qPCR assay could be used 444 to inform decisions about how soon to repeat the survey. For example, if the pfhrp2/3 445 deletions in polyclonal infections occur in medium to high transmission endemic settings, it 446 may be preferable to survey during the dry season when the multiplicity of infection is lower 447 and would allow accurate estimation of the pfhrp2/3 deletions. 448 449
Limitations 451
The challenges of confirming the absence of a gene target require careful attention to lab 452 workflow and DNA quality. First, the sensitivity of the qPCR assay demands careful 453 laboratory workflows that prevent contamination. This is true of all qPCR assays but 454 particularly important for discrimination of low-concentration deleted strains in polyclonal 455 infections. Second, while the qPCR assay was carefully designed and optimized to avoid 456 cross-binding, use of appropriate DNA controls is needed to monitor for unintentional 457 amplification of pfhrp3 by pfhrp2 primers and vice versa. We recommend including at least 458 two parasite negative controls (preferably Dd2 and HB3) for pfhrp2 and pfhrp3, respectively, 459 in each experiment. The use of only a double-deleted strain (such as 3BD5) is not 460
recommended. In addition, the qPCR assay targets only one additional single-copy parasite 461 gene while the conventional methods for pfhrp2 and pfhrp3 genotyping have employed three 462 independent parasite genes to ensure DNA quality and rule out DNA degradation (14). 463
Because the pfhrp2 and pfhrp3 qPCR amplicon lengths are shorter (98bp and 84bp 464 respectively) than typical amplicons generated by the conventional method (~ 300 -800bp), 465 detection of these targets is expected to be more reliable. If the frequency of deletions is 466 observed to be markedly increased near the limits of detection of the assay in a particular 467 study, then confirmatory testing using a second gene target could be considered. Finally, 468 due to limited conserved regions, the pfhrp2-specific primer covered known variant positions 469 present in minority of field samples in the MalariaGEN genome data. The qPCR assay was 470 optimized taking into account the known sequence variants, and the use of nucleotide 471 redundancies in the primer synthesis did not affect the yield in florescence signal (Cq value). 472
The variants within our primer sequence are relatively fewer compared to the primer and 473 probe sequences of other recently published qPCR assays (27, 31) , which we predict may 474 be challenged by sequence variation (mutations, insertions and deletion) in the primer and 475 probe sequences of pfhrp2 and pfhrp3 found in field samples from seven and nine countries 476 respectively (Table S6) . 477
